Orphenadrine Citrate Extended-Release Tablets
DEFINITION
Orphenadrine Citrate Extended-Release Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of orphenadrine citrate (C18H23NO·C6H8O7).
USP REFERENCE STANDARDS FOR PURCHASE
USP Orphenadrine Citrate RSUSP Orphenadrine Related Compound B RS
USP Orphenadrine Related Compound C RS